Skip to main content
ARDX logo

Ardelyx, Inc.

ARDXNASDAQHealthcareBiotechnology

$3.10Today:- (-)1Y −36.76%

As of Oct 28, 2026 close

Market cap
$769.01M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$3.05$8.40
Volume (live)
-
Avg. volume (3M)
4.38M

Ardelyx (ARDX) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Ardelyx used $42.48M of cash in operating activities and spent $1.49M on capital expenditures. That left free cash flow of −$43.98M.

Ardelyx Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Ardelyx, Inc. (ARDX) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Operating Activities
Net Income-61.60-39.14-66.07-67.21-158.17-94.31-94.94-91.30-64.34
Depreciation & Amortization3.062.061.291.142.811.822.502.682.64
Deferred Income Tax0.000.000.000.00-0.190.32-0.26-1.030.01
Stock Based Compensation48.9637.3813.5310.7512.0410.589.949.239.59
Change in Working Capital-31.35-49.17-43.39-19.58-11.92-3.212.999.35-13.66
Change in Accounts Receivable-14.14-35.67-14.30-7.23-0.500.750.0910.71-10.80
Change in Inventory-31.92-41.70-21.14-28.35-10.37-0.75-3.411.88-1.90
Change in Accounts Payable3.244.860.286.58-1.353.440.04-2.73-1.03
Change in Other Working Capital11.4818.91-15.87-1.222.69-6.656.27-0.510.07
Other Operating Activities-1.554.054.914.842.693.373.300.790.57
Net Cash from Operating Activities-42.48-44.81-89.72-70.04-152.55-81.44-76.48-70.27-65.19
Investing Activities
Capital Expenditures-1.49-1.01-0.34-0.06-1.87-0.32-0.33-0.31-2.36
Acquisitions0.000.000.000.00-52.8231.44-23.700.000.00
Purchases of Investments-218.92-195.16-215.23-50.33-72.74-150.85-102.67-169.03-84.01
Sales/Maturities of Investments211.46177.8584.3267.00125.55119.73126.37139.45151.66
Other Investing Activities0.000.000.001.8052.82-31.4423.70-29.5867.65
Net Cash from Investing Activities-8.96-18.32-131.2518.4250.95-31.4423.37-29.8965.29
Financing Activities
Debt Repayment48.67-1.00-1.50-33.04-19.44-0.130.0049.290.00
Common Stock Issued5.848.14120.4171.83101.1521.05154.9053.770.69
Other Financing Activities0.00-1.003.509.58-0.111.850.570.490.69
Net Cash from Financing Activities54.51106.59146.3075.3483.0022.78155.48103.550.69
Summary
Net Change in Cash3.0743.46-74.6723.71-18.60-90.10102.373.390.79
Cash at Beginning of Period64.9321.4796.1472.4391.03181.1378.7775.3874.60
Cash at End of Period68.0064.9321.4796.1472.4391.03181.1378.7775.38
Free Cash Flow-43.98-45.82-90.06-70.10-154.42-81.76-76.81-70.59-67.55
Supplemental Disclosures
Interest Paid15.7211.414.242.903.47----
Income Taxes Paid0.490.270.050.010.00----

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Ardelyx Cash Flow

What is Ardelyx's free cash flow?

Ardelyx had negative free cash flow of $43.98M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −$42.48M minus $1.49M of capital expenditures.

How much does Ardelyx spend on capital expenditures?

Ardelyx spent $1.49M on capital expenditures in fiscal 2025, compared with $1.01M a year earlier.

Does Ardelyx pay dividends or buy back shares?

Ardelyx's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition